The Rheumatologist's Role in COVID-19.
Identifieur interne : 003512 ( Ncbi/Checkpoint ); précédent : 003511; suivant : 003513The Rheumatologist's Role in COVID-19.
Auteurs : Randy Q. Cron [États-Unis] ; W Winn Chatham [États-Unis]Source :
- The Journal of rheumatology [ 0315-162X ] ; 2020.
Abstract
The novel coronavirus (severe acute respiratory syndrome; SARS-CoV-2) pandemic has spread rapidly throughout the planet. It is believed to have originated in the Wuhan province of China, but this highly contagious respiratory virus has spread to over 140 countries on 6 continents as of mid-March 2020, according to the World Health Organization. Worldwide, there have been over 164,000 cases identified and over 6500 deaths attributed to the viral infection.
DOI: 10.3899/jrheum.200334
PubMed: 32209661
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000517
- to stream PubMed, to step Curation: 000517
- to stream PubMed, to step Checkpoint: 000130
- to stream Ncbi, to step Merge: 003512
- to stream Ncbi, to step Curation: 003512
Links to Exploration step
pubmed:32209661Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Rheumatologist's Role in COVID-19.</title>
<author><name sortKey="Cron, Randy Q" sort="Cron, Randy Q" uniqKey="Cron R" first="Randy Q" last="Cron">Randy Q. Cron</name>
<affiliation wicri:level="1"><nlm:affiliation>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711</wicri:regionArea>
<wicri:noRegion>Alabama 35233-1711</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chatham, W Winn" sort="Chatham, W Winn" uniqKey="Chatham W" first="W Winn" last="Chatham">W Winn Chatham</name>
<affiliation wicri:level="1"><nlm:affiliation>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711</wicri:regionArea>
<wicri:noRegion>Alabama 35233-1711</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32209661</idno>
<idno type="pmid">32209661</idno>
<idno type="doi">10.3899/jrheum.200334</idno>
<idno type="wicri:Area/PubMed/Corpus">000517</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000517</idno>
<idno type="wicri:Area/PubMed/Curation">000517</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000517</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000130</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000130</idno>
<idno type="wicri:Area/Ncbi/Merge">003512</idno>
<idno type="wicri:Area/Ncbi/Curation">003512</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003512</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Rheumatologist's Role in COVID-19.</title>
<author><name sortKey="Cron, Randy Q" sort="Cron, Randy Q" uniqKey="Cron R" first="Randy Q" last="Cron">Randy Q. Cron</name>
<affiliation wicri:level="1"><nlm:affiliation>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711</wicri:regionArea>
<wicri:noRegion>Alabama 35233-1711</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chatham, W Winn" sort="Chatham, W Winn" uniqKey="Chatham W" first="W Winn" last="Chatham">W Winn Chatham</name>
<affiliation wicri:level="1"><nlm:affiliation>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary HLH in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI. Address correspondence to Dr. R.Q. Cron, Children's of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, Alabama 35233-1711</wicri:regionArea>
<wicri:noRegion>Alabama 35233-1711</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of rheumatology</title>
<idno type="ISSN">0315-162X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The novel coronavirus (severe acute respiratory syndrome; SARS-CoV-2) pandemic has spread rapidly throughout the planet. It is believed to have originated in the Wuhan province of China, but this highly contagious respiratory virus has spread to over 140 countries on 6 continents as of mid-March 2020, according to the World Health Organization. Worldwide, there have been over 164,000 cases identified and over 6500 deaths attributed to the viral infection.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Cron, Randy Q" sort="Cron, Randy Q" uniqKey="Cron R" first="Randy Q" last="Cron">Randy Q. Cron</name>
</noRegion>
<name sortKey="Chatham, W Winn" sort="Chatham, W Winn" uniqKey="Chatham W" first="W Winn" last="Chatham">W Winn Chatham</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003512 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 003512 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:32209661 |texte= The Rheumatologist's Role in COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:32209661" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |